CRB
Chad R. Baker Portfolio holdings
AUM
$538M
This Quarter Return
-10.74%
1 Year Return
+20.8%
3 Year Return
+87.18%
5 Year Return
+140.51%
10 Year Return
–
AUM
$232M
AUM Growth
+$232M
(-15%)
Cap. Flow
-$9.92M
Cap. Flow
% of AUM
-4.28%
Top 10 Holdings %
Top 10 Hldgs %
40.13%
Holding
56
New
1
Increased
–
Reduced
8
Closed
3
Top Buys
| 1 |
Cigna
CI
|
$1.11M |
Top Sells
| 1 |
ESRX
Express Scripts Holding Company
ESRX
|
$2.28M |
| 2 |
Norfolk Southern
NSC
|
$1.67M |
| 3 |
J.M. Smucker
SJM
|
$1.5M |
| 4 |
Gilead Sciences
GILD
|
$1.2M |
| 5 |
Merck
MRK
|
$1.05M |
Sector Composition
| 1 | Healthcare | 28.04% |
| 2 | Industrials | 18.35% |
| 3 | Technology | 15.43% |
| 4 | Communication Services | 10.85% |
| 5 | Financials | 9.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Home Depot
HD
$406B
| $4.12M | 1.78% |
24,000
| – | – |
|
27
IPG Photonics
IPGP
$3.33B
| $4.09M | 1.76% |
36,090
| – | – |
|
28
GE Aerospace
GE
$289B
| $3.25M | 1.4% |
429,296
| – | – |
|
29
Lowe's Companies
LOW
$145B
| $3.2M | 1.38% |
34,600
| – | – |
|
30
Walmart
WMT
$777B
| $3.07M | 1.33% |
33,000
| – | – |
|
|
RTN
31
DELISTED
Raytheon Company
RTN
| $3.07M | 1.32% |
20,000
| – | – |
|
32
Colgate-Palmolive
CL
$68.1B
| $3.05M | 1.31% |
51,200
| – | – |
|
33
Exxon Mobil
XOM
$490B
| $3M | 1.3% |
44,040
-12,500
| -22% | -$852K |
|
34
Stryker
SYK
$149B
| $3M | 1.29% |
19,145
| – | – |
|
35
Comcast
CMCSA
$125B
| $2.66M | 1.15% |
78,000
| – | – |
|
36
Alphabet (Google) Class C
GOOG
$2.53T
| $2.34M | 1.01% |
2,256
| – | – |
|
37
PepsiCo
PEP
$208B
| $2.32M | 1% |
21,000
| – | – |
|
38
Teladoc Health
TDOC
$1.34B
| $2.3M | 0.99% |
46,345
| – | – |
|
|
39
J.M. Smucker
SJM
$11.6B
| $2.21M | 0.95% |
23,650
-16,000
| -40% | -$1.5M |
|
40
Zoetis
ZTS
$67.3B
| $2.12M | 0.92% |
24,818
| – | – |
|
41
CSX Corp
CSX
$59.9B
| $2.11M | 0.91% |
34,000
| – | – |
|
42
Adobe
ADBE
$146B
| $2.04M | 0.88% |
9,000
| – | – |
|
43
DuPont de Nemours
DD
$31.5B
| $1.37M | 0.59% |
25,640
| – | – |
|
44
International Flavors & Fragrances
IFF
$16.9B
| $1.34M | 0.58% |
10,000
| – | – |
|
45
Fortive
FTV
$15.8B
| $1.23M | 0.53% |
18,150
| – | – |
|
46
AT&T
T
$208B
| $1.14M | 0.49% |
40,000
| – | – |
|
|
47
Cigna
CI
$80.4B
| $1.11M | 0.48% |
+5,841
| New | +$1.11M |
|
48
Biogen
BIIB
$20.1B
| $1.07M | 0.46% |
3,550
| – | – |
|
49
Perrigo
PRGO
$3.21B
| $836K | 0.36% |
21,565
-10,000
| -32% | -$388K |
|
50
Novartis
NVS
$244B
| $800K | 0.35% |
9,315
| – | – |
|